Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'Enterococcus faecium' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 397 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Singh, N; Gayowski, T; Rihs, JD; Wagener, MM; Marino, IR
      Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: A longitudinal study of antimicrobial susceptibility patterns

      LIVER TRANSPLANTATION
    2. Losteinkit, C; Uchiyama, K; Ochi, S; Takaoka, T; Nagahisa, K; Shioya, S
      Characterization of bacteriocin N15 produced by Enterococcus faecium N15 and cloning of the related genes

      JOURNAL OF BIOSCIENCE AND BIOENGINEERING
    3. Bonfiglio, G; Furneri, PM
      Novel streptogramin antibiotics

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    4. Ziglam, HM; Finch, RG
      Limitations of presently available glycopeptides in the treatment of Gram-positive infection

      CLINICAL MICROBIOLOGY AND INFECTION
    5. Marchese, A; Schito, GC
      The oxazolidinones as a new family of antimicrobial agent

      CLINICAL MICROBIOLOGY AND INFECTION
    6. Bouza, E; Munoz, P
      Linezolid: pharmacokinetic characteristics and clinical studies

      CLINICAL MICROBIOLOGY AND INFECTION
    7. Strausbaugh, LJ
      Emerging health care-associated infections in the geriatric population

      EMERGING INFECTIOUS DISEASES
    8. McGowan, JE
      Economic impact of antimicrobial resistance

      EMERGING INFECTIOUS DISEASES
    9. Peterson, LR; Noskin, GA
      New technology for detecting multidrug-resistant pathogens in the clinicalmicrobiology laboratory

      EMERGING INFECTIOUS DISEASES
    10. Elmer, GW
      Probiotics: "Living drugs"

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    11. Bain, KT; Wittbrodt, ET
      Linezolid for the treatment of resistant gram-positive cocci

      ANNALS OF PHARMACOTHERAPY
    12. Tenover, FC
      Development and spread of bacterial resistance to antimicrobial agents: Anoverview

      CLINICAL INFECTIOUS DISEASES
    13. Lautenbach, E; Patel, JB; Bilker, WB; Edelstein, PH; Fishman, NO
      Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiellapneumoniae: Risk factors for infection and impact of resistance on outcomes

      CLINICAL INFECTIOUS DISEASES
    14. Harris, AD; Karchmer, TB; Carmeli, Y; Samore, MH
      Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: A systematic review

      CLINICAL INFECTIOUS DISEASES
    15. Rubinstein, E; Cammarata, SK; Oliphant, TH; Wunderink, RG
      Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenterstudy

      CLINICAL INFECTIOUS DISEASES
    16. Al-Doori, Z; Hill, RLR; Casewell, MW
      Use of a 'Miniprep' for rapid extraction of plasmids from vancomycin- and gentamicin-resistant Enterococcus faecium

      WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
    17. Kariuki, S; Hart, CA
      Global aspects of antimicrobial-resistant enteric bacteria

      CURRENT OPINION IN INFECTIOUS DISEASES
    18. Morovsky, M; Pristas, P; Javorsky, P; Nes, IF; Holo, H
      Isolation and characterization of enterocin BC25 and occurrence of the entA gene among ruminal Gram-positive cocci

      MICROBIOLOGICAL RESEARCH
    19. McKinnon, PS; Tam, VH
      New antibiotics for infections caused by resistant organisms

      SUPPORTIVE CARE IN CANCER
    20. Leclercq, R; Nicolas-Chanoine, MH; Nordmann, P; Philippon, A; Marchais, P; Buu-Ho, A; Chardon, H; Dabernat, H; Doucet-Populaire, F; Grasmick, C; Legrand, P; Muller-Serieys, C; Nguyen, J; Ploy, MC; Reverdy, ME; Weber, M; Courcol, RJ
      Multicenter evaluation of an automated system using selected bacteria thatharbor challenging and clinically relevant mechanisms of resistance to antibiotics

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    21. Presterl, E; Mueller-Uri, P; Grisold, A; Georgopoulos, A; Graninger, W
      Ciprofloxacin- and methicillin-resist ant Staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    22. Sorum, H; Sunde, M
      Resistance to antibiotics in the normal flora of animals

      VETERINARY RESEARCH
    23. Floret, N; Thouverez, M; Thalamy, B; Estavoyer, JM; Talon, D
      Evaluation of vancomycin use in a large university-affiliated hospital in eastern France in 1999

      PHARMACY WORLD & SCIENCE
    24. Baden, LR; Maguire, JH
      Gastrointestinal infections in the immuncompromised host

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    25. Jones, RN; Ballow, CH; Biedenbach, DJ
      Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox (R) Antimicrobial Potency Study (ZAPS) in the United States

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    26. Boerlin, P; Eugster, S; Gaschen, F; Straub, R; Schawalder, P
      Transmission of opportunistic pathogens in a veterinary teaching hospital

      VETERINARY MICROBIOLOGY
    27. Champney, WS; Tober, CL
      Structure-activity relationships for six ketolide antibiotics

      CURRENT MICROBIOLOGY
    28. Zabala, A; Martin, R; Haza, A; Fernandez, L; Morales, P; Rodriguez, JM
      Inhibition of the proliferation of myeloma cells by the meat origin strainEnterococcus faecium CH3

      MEAT SCIENCE
    29. Dancer, SJ
      The problem with cephalosporins

      Journal of antimicrobial chemotherapy
    30. Jones, RN; Hare, RS; Sabatelli, FJ
      In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial

      Journal of antimicrobial chemotherapy
    31. Simon, A; Fleischhack, G
      Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology patients.

      KLINISCHE PADIATRIE
    32. Simon, A; Fleischhack, G; Marklein, G; Ritter, J
      Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients.

      KLINISCHE PADIATRIE
    33. Gunderson, BW; Ross, GH; Ibrahim, KH; Rotschafer, JC
      What do we really know about antibiotic pharmacodynamics?

      PHARMACOTHERAPY
    34. Poutsiaka, DD
      Antimicrobial resistance in the chronically critically ill patient

      CLINICS IN CHEST MEDICINE
    35. Grau, S; Alvarez-Lerma, F; Marin, M; Gimeno, JL
      Problems and current solutions for the treatment of infections caused by gram-positive microorganisms

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    36. Kleerebezem, M; Quadri, LE
      Peptide pheromone-dependent regulation of antimicrobial peptide productionin Gram-positive bacteria: a case of multicellular behavior

      PEPTIDES
    37. Mylotte, JM; Goodnough, S; Tayara, A
      Antibiotic-resistant organisms among long-term care facility residents on admission to an inpatient geriatrics unit: Retrospective and prospective surveillance

      AMERICAN JOURNAL OF INFECTION CONTROL
    38. Ennahar, S; Asou, Y; Zendo, T; Sonomoto, K; Ishizaki, A
      Biochemical and genetic evidence for production of enterocins A and B by Enterococcus faecium WHE 81

      INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
    39. Audisio, MC; Oliver, G; Apella, MC
      Effect of different complex carbon sources on growth and bacteriocin synthesis of Enterococcus faecium

      INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
    40. Berends, BR; Van den Bogaard, AEJM; Van Knapen, F; Snijders, JMA
      Human health hazards associated with the administration of antimicrobials to slaughter animals - part II. An assessment of the risks of resistant bacteria in pigs and pork

      VETERINARY QUARTERLY
    41. Jensen, LB; Baloda, S; Boye, M; Aarestrup, FM
      Antimicrobial resistance among Pseudomonas spp. and the Bacillus cereus group isolated from Danish agricultural soil

      ENVIRONMENT INTERNATIONAL
    42. Fung, HB; Kirschenbaum, HL; Ojofeitimi, BO
      Linezolid: An oxazolidinone antimicrobial agent

      CLINICAL THERAPEUTICS
    43. Allington, DR; Rivey, MP
      Quinupristin/dalfopristin: A therapeutic review

      CLINICAL THERAPEUTICS
    44. Diekema, DJ; Jones, RN
      Oxazolidinone antibiotics

      LANCET
    45. Chevalier, P; Rey, J; Pasquier, O; Rouzier-Panis, R; Harding, N; Montay, G
      Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid (R)) in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    46. McGowan, JE
      Increasing threat of Gram-positive bacterial infections in the intensive care unit setting

      CRITICAL CARE MEDICINE
    47. Schentag, JJ
      Antimicrobial management strategies for Gram-positive bacterial resistancein the intensive care unit

      CRITICAL CARE MEDICINE
    48. DeLisle, S; Perl, TM
      Antimicrobial management measures to limit resistance: A process-based conceptual framework

      CRITICAL CARE MEDICINE
    49. Warren, DK; Fraser, VJ
      Infection control measures to limit antimicrobial resistance

      CRITICAL CARE MEDICINE
    50. Dailey, CF; Dileto-Fang, CL; Buchanan, LV; Oramas-Shirey, MP; Batts, DH; Ford, CW; Gibson, JK
      Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    51. Coyle, EA; Rybak, J
      Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    52. Chiosis, G; Boneca, IG
      Selective cleavage of D-Ata-D-Lac by small molecules: Re-sensitizing resistant bacteria to vancomycin

      SCIENCE
    53. Knudsen, KEB
      Development of antibiotic resistance and options to replace antimicrobialsin animal diets

      PROCEEDINGS OF THE NUTRITION SOCIETY
    54. Morovsky, M; Pristas, P; Javorsky, P
      Bacteriocins of ruminal bacteria

      FOLIA MICROBIOLOGICA
    55. Patterson, JE
      Antibiotic utilization - Is there an effect on antimicrobial resistance?

      CHEST
    56. Ling, TKW; Fung, KSC; Cheng, AFB
      In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid)

      CHEMOTHERAPY
    57. Ellerbroek, L; Richter, P; Bouchette, L; Hildebrandt, G
      Isolation and identification of glycopeptid-resistant enteroccus species

      ARCHIV FUR GEFLUGELKUNDE
    58. Viklund, C; Sjogren, A; Irgum, K; Nes, I
      Chromatographic interactions between proteins and sulfoalkylbetaine-based zwitterionic copolymers in fully aqueous low-salt buffers

      ANALYTICAL CHEMISTRY
    59. Elsner, HA; Sobottka, I; Feucht, HH; Harps, E; Haun, C; Mack, D; Ganschow, R; Laufs, R; Kaulfers, PM
      Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German University Pediatric Hospital

      INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
    60. Werner, G; Hildebrandt, B; Klare, I; Witte, W
      Linkage of determinants for streptogramin A, macrolide-lincosamide-streptogramin B, and chloramphenicol resistance on a conjugative plasmid in Enterococcus faecium and dissemination of this cluster among streptogramin-resistant enterococci

      INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
    61. Asano, Y; Lubbehusen, TL
      Enzymes acting on peptides containing D-amino acid

      JOURNAL OF BIOSCIENCE AND BIOENGINEERING
    62. Monroe, S; Polk, R
      Antimicrobial use and bacterial resistance

      CURRENT OPINION IN MICROBIOLOGY
    63. Perichon, B; Courvalin, P
      Update on vancomycin resistance

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    64. Perichon, B; Courvalin, P
      Update on vancomycin resistance

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    65. Bush, K; Macielag, M
      New approaches in the treatment of bacterial infections

      CURRENT OPINION IN CHEMICAL BIOLOGY
    66. Klein, G; Hallmann, C; Casas, IA; Abad, J; Louwers, J; Reuter, G
      Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods

      JOURNAL OF APPLIED MICROBIOLOGY
    67. Oscariz, JC; Pisabarro, AG
      Characterization and mechanism of action of cerein 7, a bacteriocin produced by Bacillus cereus Bc7

      JOURNAL OF APPLIED MICROBIOLOGY
    68. Harthug, S; Digranes, A; Hope, O; Kristiansen, BE; Allum, AG; Langeland, N
      Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium

      CLINICAL MICROBIOLOGY AND INFECTION
    69. Fontana, R; Cornaglia, G; Ligozzi, M; Mazzariol, A
      The final goal: penicillin-binding proteins and the target of cephalosporins

      CLINICAL MICROBIOLOGY AND INFECTION
    70. Carbon, C
      MRSA and MRSE: is there an answer?

      CLINICAL MICROBIOLOGY AND INFECTION
    71. Carfagna, P; Tarasi, A; Cassone, M; Del Grosso, MF; Bianco, G; Venditti, M
      Prosthetic biologic valve endocarditis caused by a vancomycin-resistant (vanA) Enterococcus faecalis: Case report

      JOURNAL OF CHEMOTHERAPY
    72. Cupo-Abbott, J; Louie, SG; Rho, JP
      Linezolid - A synthetic oxazolidinone antimicrobial for treatment of serious gram-positive infections

      FORMULARY
    73. Richardson, LP; Wiseman, SW; Malani, PN; Lyons, MJ; Kauffman, CA
      Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff

      MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE
    74. May, AK; Melton, SM; McGwin, G; Cross, JM; Moser, SA; Rue, LW
      Reduction of vancomycin-resistant enterococcal infections by limitation ofbroad-spectrum cephalosporin use in a trauma and burn intensive care unit

      SHOCK
    75. Dahms, R; Carlson, M; Lohr, B; Beilman, G
      Selective digestive tract decontamination and vancomycin-resistant Enterococcus isolation in the surgical intensive care unit

      SHOCK
    76. Tollefson, L; Miller, MA
      Antibiotic use in food animals: Controlling the human health impact

      JOURNAL OF AOAC INTERNATIONAL
    77. Bonomo, RA
      Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases

      CLINICAL INFECTIOUS DISEASES
    78. Plouffe, JF
      Emerging therapies for serious gram-positive bacterial infections: A focuson linezolid

      CLINICAL INFECTIOUS DISEASES
    79. Singh, N; Paterson, DL; Chang, FY; Gayowski, T; Squier, C; Wagener, MM; Marino, IR
      Methicillin-resistant Staphylococcus aureus: The other emerging resistant gram-positive coccus among liver transplant recipients

      CLINICAL INFECTIOUS DISEASES
    80. Chien, JW; Kucia, ML; Salata, RA
      Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections

      CLINICAL INFECTIOUS DISEASES
    81. Brandt, JJ; Chatwood, LL; Crowder, MW
      Analysis of three overexpression systems for VanX, the zinc(II) dipeptidase required for high-level vancomycin resistance in bacteria

      PROTEIN EXPRESSION AND PURIFICATION
    82. Yang, KW; Brandt, JJ; Chatwood, LL; Crowder, MW
      Phosphonamidate and phosphothioate dipeptides as potential inhibitors of VanX

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    83. Marchand, J; Vandenplas, Y
      Micro-organisms administered in the benefit of the host: myths and facts

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    84. Gilleece, AC; Fenelon, L
      Unusual infections and novel therapy in the immunocompromised host

      CURRENT OPINION IN INFECTIOUS DISEASES
    85. Rakita, RM; Quan, VC; Jacques-Palaz, K; Singh, KV; Arduino, RC; Mee, M; Murray, BE
      Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    86. Bager, F
      DANMAP: monitoring antimicrobial resistance in Denmark

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    87. van den Bogaard, AE; Stobberingh, EE
      Epidemiology of resistance to antibiotics - Links between animals and humans

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    88. Aarestrup, FM
      Occurrence, selection and spread of resistance to antimicrobial agents used for growth promotion for food animals in Denmark

      APMIS
    89. Farr, BM
      Reasons for noncompliance with infection control guidelines

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    90. Strausbaugh, LJ; Joseph, CL
      The burden of infection in long-term care

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    91. John, JE; Rice, LB
      The microbial genetics of antibiotic cycling

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    92. McGowan, JE
      Strategies for study of the role of cycling on antimicrobial use and resistance

      INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
    93. Kaye, KS; Fraimow, HS; Abrutyn, E
      Pathogens resistant to antimicrobial agents - Epidemiology, molecular mechanisms, and clinical management

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    94. Lundstrom, TS; Sobel, JD
      Antibiotics for gram-positive bacterial infections - Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    95. Gray, JW; Darbyshire, PJ; Beath, SV; Kelly, D; Mann, JR
      Experience with quinupristin/dalfopristin in treating infections with vancomycin-resistant Enterococcus faecium in children

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    96. Leone, M; Ayem, ML; Martin, C
      Glycopeptides.

      ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION
    97. Dowzicky, M; Talbot, GH; Feger, C; Prokocimer, P; Etienne, J; Leclercq, R
      Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid (R)) during a worldwide clinical program

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    98. Kugler, KC; Denys, GA; Wilson, ML; Jones, RN
      Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin/dalfopristin): Case reports from the SENTRY antimicrobial surveillance program

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    99. Gluck, T; Linde, HJ; Wiegrebe, E; Lehn, N; Reng, M; Scholmerich, J
      Restriction of vancomycin use in a German university hospital

      MEDIZINISCHE KLINIK
    100. Hwang, SH; Kim, MN; Pai, CH; Huh, DH; Shin, WS
      In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea

      YONSEI MEDICAL JOURNAL


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 02:05:10